文献速递临床试验与 GCP流行病学与生物统计

ESCAlate:针对青少年和成人注意缺陷多动障碍的自适应治疗研究方案

ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-05-18

ESCAlate 是一项随机对照试验,计划纳入 279 名 16–45 岁注意缺陷多动障碍(ADHD)患者,先随机分配至面对面心理教育、电话辅助自助(TASH)或等待对照组,再根据症状严重程度分层进入自适应治疗步骤,以评估阶梯式治疗对 ADHD 症状严重程度及功能结局的效果。

要点

  • ESCAlate 采用随机对照设计评估 ADHD 阶梯式自适应治疗。
  • 第一步随机比较面对面心理教育、电话辅助自助与等待对照。
  • 第二步按应答程度分层给予咨询、神经反馈或药物治疗。

核心结论

  • 研究旨在通过随机对照试验确定针对不同 ADHD 症状严重程度的优化干预方案。
  • 将评估基于证据的阶梯式治疗干预在减少 ADHD 症状严重程度方面的疗效。

研究设计与样本

  • 随机对照试验,计划纳入 279 名 16–45 岁 ADHD 患者。
  • 第一步随机分配至面对面心理教育、电话辅助自助(TASH)或等待对照组(Step 1)。
  • 等待对照组在 3 个月等待期后接受 TASH 治疗。
  • 第二步根据剩余 ADHD 症状严重程度将参与者分为完全应答者、部分应答者和无应答者(Step 2)。
  • 完全应答者接受咨询,部分应答者接受仅咨询或咨询联合神经反馈(NF),无应答者接受仅药物治疗或药物治疗联合 NF,随后进入 3 个月无干预期。

主要发现

  • 主要结局为 ADHD 症状严重程度的减少。
  • 次要结局包括功能结局,如生活质量、愤怒管理、心理社会幸福感提升。
  • 将在每个干预步骤中研究治疗应答和无应答的预测因素。
  • 还将探索性别差异。

临床怎么用

  • 研究结果可为 ADHD 阶梯式治疗策略的制定提供随机对照证据。
  • 自然样本设计避免高度选择性纳入或排除标准,可能增强结果的外推性。

局限性

  • 研究方案未报告研究已完成的疗效数据或中期分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the last decade, a wide range of attention-deficit/hyperactivity disorder (ADHD) treatment approaches for adults, including both pharmacological interventions and psychosocial treatments, have been proposed and observed to be efficient. In practice, individual treatment concepts are based on results of clinical studies as well as international guidelines (NICE Guidelines) that recommend a step-by-step treatment approach. Since the evidence supporting this approach is limited, the aim of the present study is to determine an optimal intervention regarding severity levels of ADHD symptomatology conducting a randomized controlled trial. METHOD: We aim to include 279 ADHD subjects aged between 16 and 45 years. First, participants are randomized to either a face-to-face psychoeducation, telephone assisted self-help (TASH), or a waiting control group (Step 1). All participants assigned to the control group are treated using TASH after a 3-month waiting period. Participants are then allocated to one of three groups, based on their remaining severity level of ADHD symptoms, as (1) full responder, (2) partial responder, or (3) non-responder (Step 2). Full responders receive counseling, partial responders receive either counseling only or counseling and neurofeedback (NF), and non-responders receive either pharmacological treatment only or pharmacological treatment and NF, followed by a 3 month period without intervention. DISCUSSION: The naturalistic sample is one of the study's advantages, avoiding highly selective inclusion or exclusion criteria. The efficacy of an evidence-based stepped care intervention is explored by primary (reduction of severity of ADHD symptoms) and secondary outcomes (functional outcomes, e.g., quality of life, anger management, enhancement of psychosocial well-being). Predictors of therapeutic response and non-response are being investigated at each step of intervention. Further, sex differences are also being explored. TRIAL REGISTRATION: This study is registered by the German Trial Register (reference number: DRKS00008975 ), 23 October 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zinnow T, Banaschewski T, Fallgatter AJ, et al. ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29776383. doi:10.1186/s13063-018-2665-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。